Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Meta is pulling back from recent highs, but fundamentals still support owning the stock. Strong free cash flow ($48.25B), healthy ROE (29%), and a reasonable P/E (~22x) coupled with continued ad and data-center-driven AI demand make a mid-term long trade attractive. Enter near $610 with a tight stop and a two-stage target plan tied to a recovery in…
U.S. and Chinese officials are exploring the launch of formal discussions on artificial intelligence ahead of a planned summit in Beijing next week between President Donald Trump and President Xi Jinping. The talks would focus on risks such as unpredictable model behavior, autonomous military applications and AI-enabled attacks by non-state actors.…
Vishwas Setia, the Chief Financial Officer of MapLight Therapeutics, Inc. (NASDAQ: MPLT), has completed a sale of company stock totaling more than $1 million. The transaction involved 36,371 shares of common stock and took place over a three-day period from May 4 to May 6, 2026. These sales were conducted through a Rule 10b5-1 trading plan that had…
Sarah Oughtred, the Chief Financial Officer of FIGS, Inc. (NYSE:FIGS), completed a sale of 23,597 shares of the company’s Class A Common Stock on May 4, 2026. The transaction, which comprised several individual trades, resulted in a total value of roughly $338,237. These sales were conducted at a weighted average price of $14.3339 per share, with i…
Heather L. Hasson, the Executive Chairman of FIGS, Inc. (NASDAQ:FIGS), has completed a sale of 32,385 shares of the company's Class A Common Stock. The transaction, which took place on May 4, 2026, resulted in total proceeds of $464,203. According to regulatory filings, these sales were conducted at a weighted average price of $14.3339 per share, w…
Dominic Ng, the Chief Executive Officer of East West Bancorp Inc. (NASDAQ:EWBC), has completed a series of stock sales totaling approximately $3.76 million. These transactions occurred on May 6, 2026, during a period where the company's shares have demonstrated significant upward momentum, trading near their annual highs. The sale took place while …
MapLight Therapeutics (NASDAQ:MPLT) has disclosed a significant insider transaction involving its General Counsel, Kristopher Hanson. On May 4, 2026, Mr. Hanson sold a portion of his holdings in the company's common stock, totaling approximately $388,176. The sale consisted of 13,917 shares, which were liquidated at varying price points between $27…
Erin Pennock Foff, the Chief Medical Officer at MapLight Therapeutics, Inc. (NASDAQ:MPLT), has completed a series of stock sales totaling approximately $1,427,594. The transactions, which occurred between May 4 and May 6, 2026, involved the sale of 50,280 shares of common stock. These disposals were conducted through a Rule 10b5-1 trading plan that…
Lillie James Woodruff, the Chief Scientific Officer at MapLight Therapeutics, Inc. (MPLT), has completed a series of stock sales totaling approximately $1.47 million. The transactions, which involved 51,727 shares of voting common stock, took place between May 4 and May 6, 2026. These sales were conducted under a Rule 10b5-1 trading plan that was e…
Christopher A. Kroeger, the Chief Executive Officer of MapLight Therapeutics, Inc. (NASDAQ:MPLT), has completed a sale of common stock totaling $1,412,235. The transaction involved 49,744 shares and was carried out through a series of trades between May 4 and May 6, 2026. These sales were executed at price points ranging from $27.50 to $30.08 per s…
Nick Khan, serving as a director for TKO Group Holdings, Inc. (NASDAQ:TKO), has completed a sale of company stock totaling approximately $1.77 million. The transactions occurred on May 4, 2026, involving the disposal of 9,518 shares of Class A Common Stock. These sales were executed according to a Rule 10b5-1 trading plan that Mr. Khan had previous…
Roy D. Baynes, a member of the board of directors at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of common stock totaling $209,925. The transaction occurred on May 5, 2026, as part of a Rule 10b5-1 trading plan that was established back in November 2025. This movement follows a period of substantial stock performance for Travere…
Jeff Zhou, a member of the board of directors at Monolithic Power Systems Inc. (NASDAQ: MPWR), has completed a series of stock transactions totaling approximately $2.43 million. The sales, which took place over a two-day period in early May 2026, come as the company maintains high momentum following significant year-over-year gains and strong quart…
Travere Therapeutics, Inc. (NASDAQ:TVTX) has seen recent insider activity involving its Chief Commercial Officer, Peter Heerma. Following the successful vesting of performance-based equity units, Mr. Heerma executed a sale of common stock intended specifically to cover tax obligations. This transaction occurs amid a period of significant stock pric…
Christopher R. Cline, the Chief Financial Officer of Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed two separate transactions involving the sale of company common stock. The total value of the shares sold amounted to $115,368, with transaction prices ranging between $43.95 and $46.65 per share. These sales follow a period where the executi…
Eric M. Dube, the Chief Executive Officer of Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of 22,500 shares of common stock valued at $988,875. The transaction, which occurred on May 6, 2026, was conducted at a price of $43.95 per share. This move followed the vesting of performance-based restricted stock units (PSUs) triggered by…
Todd Krasnow, a director at Symbotic Inc. (NASDAQ:SYM), has completed a sale of company stock totaling $115,217. The transaction was conducted through Inlet View, Inc., an entity where Mr. Krasnow serves as President and CEO, following a structured trading plan established in late 2025. This move comes as the company navigates a period of divergent…
U.S. stock futures pulled back modestly Wednesday evening following a day in which major benchmarks reached fresh record highs. Investor optimism that tensions with Iran may be easing, combined with a rally in chipmakers after strong results from AMD, propelled the market earlier in the session. Futures declines were small as traders digested the g…
Elizabeth E. Reed, serving as the Chief Legal Officer and General Counsel for Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed a series of stock transactions totaling approximately $1,092,657. These sales took place over a three-day period between May 4 and May 6, 2026. The transaction activity occurs while the company's stock is trading at …
Jula Inrig, the Chief Medical Officer at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a series of stock transactions totaling approximately $1,015,085. Between May 4 and May 6, 2026, Ms. Inrig sold a cumulative total of 22,485 shares of the company's common stock. The pricing for these individual sales fluctuated between a low of $43.95…
Jeffrey A. Meckler, a director at Travere Therapeutics, Inc. (NASDAQ: TVTX), has completed a sale of company common stock totaling $360,000. The transaction, which took place on May 4, 2026, involved the sale of 8,000 shares at a price point of $45.00 per share. This activity occurred against a backdrop of significant recent price movement for the …
William E. Rote, serving as the Chief Research Officer for Travere Therapeutics, Inc. (NASDAQ:TVTX), has completed a sale of company common stock totaling $121,433. The transaction, which involved 2,763 shares, occurred at a price point of $43.95 per share. This movement follows a recent acquisition of shares through the vesting of performance-base…
Ryman Hospitality Properties, Inc., a leading hospitality REIT specializing in upscale convention center resorts and entertainment, announced a second quarter cash dividend of $1.20 per share payable on July 15, 2026. The company operates a portfolio of major convention center hotels and entertainment venues primarily in the U.S., managed by Marrio…
Masaru Matsuda, who serves as the Executive Vice President and Chief Legal Officer at Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), has completed the sale of common stock totaling $192,415. These transactions took place on May 4, 2026, involving two distinct types of sales that reflect different financial motivations ranging from pre-planned divest…
Christopher S. Cook, who serves as the President of the Products Division at Ultra Clean Holdings, Inc. (NASDAQ:UCTT), has completed a sale of company common stock totaling $848,921. The transaction, which took place on May 4, 2026, occurred while the company's stock was trading near its annual highs following a period of significant growth. Despit…
